Isomorphic raises $2.1B to push AI-designed drugs toward clinic
DeepMind spinout Isomorphic Labs raised $2.1 billion as Demis Hassabis now points to first AI-designed drugs entering human trials by late 2026.
AlphaFoldのニュースと分析
AlphaFoldに関する製品動向と業界分析を全3件掲載しています。